Dyslipidemia Therapy

NP Certification Q&A

A 65-year-old woman has hypertension, dyslipidemia, type 2 diabetes, a 50 pack-year history of cigarette smoking, currently smoking ½ PPD,  and stage 3B chronic kidney disease (CKD)  (GFR = 37 mL/min/1.73 m2). She is not currently taking any dyslipidemia therapy and her LDL= 140 mg/dL. Which of the following represents the most appropriate pharmacologic intervention for treatment of dyslipidemia?

A. Owing to her age and comorbidity, no further intervention is required.

B. Moderate-intensity statin therapy is the preferred treatment option.

C. Niacin should be prescribed.

D. The use of ezetimibe (Zetia®) will likely be sufficient to achieve dyslipidemia control.

---
YouTube: https://www.youtube.com/watch?v=up_iIweB9Ic&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=27

Visit fhea.com to learn more!

More description

A 65-year-old woman has hypertension, dyslipidemia, type 2 diabetes, a 50 pack-year history of cigarette smoking, currently smoking ½ PPD,  and stage 3B chronic kidney disease (CKD)  (GFR = 37 mL/min/1.73 m2). She is not currently taking any dyslipidemia therapy and her LDL= 140 mg/dL. Which of the following represents the most appropriate pharmacologic intervention for treatment of dyslipidemia?

A. Owing to her age and comorbidity, no further intervention is required.

B. Moderate-intensity statin therapy is the preferred treatment option.

C. Niacin should be prescribed.

D. The use of ezetimibe (Zetia®) will likely be sufficient to achieve dyslipidemia control.

---
YouTube: https://www.youtube.com/watch?v=up_iIweB9Ic&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=27

Visit fhea.com to learn more!

2023-07-17 12 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.